Citation only
via Europe PMC
Translating Geroscience Into Clinical Practice: Molecular Targets, Emerging Therapies, and Lifestyle Strategies for Healthy Longevity.
Pinnelli VB, T SB, C A J, Mathew HA, Kandi V, G R M, Sam KT, Sucharitha AS, M S D, Batchu SVC, C R.
Cureus · 2026
Epigenetic alterations
Dysbiosis
Deregulated nutrient-sensing
Cellular senescence
Chronic inflammation
Senolytics
Rapamycin / mTOR inhibition
Metformin
Spermidine
Partial reprogramming (OSK)
Human
Systematic review
Cohort study
Review
Abstract
Population aging has intensified interest in interventions that preserve function and delay multiple chronic diseases by modifying the biology of aging. The field now spans molecular geroscience, experimental therapeutics, biomarker development, and preventive medicine, but the maturity of evidence varies substantially. This study aimed to synthesize foundational mechanisms, clinical and translational strategies, and lifestyle determinants relevant to healthy longevity, while distinguishing established practice from emerging or unproven interventions. A critical narrative review of PubMed/MEDLINE and reference lists was conducted from January 2000 through August 2026. Priority was given to consensus frameworks, human randomized trials, prospective cohorts, systematic reviews, and influential mechanistic studies. Evidence was interpreted according to study design, clinical relevance, reproducibility, and safety. The expanded 12-hallmark framework depicts aging as an interconnected network involving genomic damage, impaired maintenance systems, maladaptive stress responses, inflammation, and dysbiosis. Senolytics(definition), epigenetic reprogramming, nicotinamide adenine dinucleotide (NAD+) augmentation, mechanistic target of mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">rapamycin(definition) (mTOR) inhibition, metformin, and spermidine are biologically plausible, but none yet has definitive evidence of extending lifespan in healthy humans. Epigenetic clocks are useful research biomarkers, although a lower clock estimate is not synonymous with rejuvenation or proven risk reduction. By contrast, cardiorespiratory fitness, muscle strength, dietary quality, restorative and regular sleep, avoidance of tobacco, management of cardiometabolic risk, and social connection are supported by much stronger human-outcome evidence. Responsible longevity medicine should integrate geroscience with rigorous preventive care, use biomarkers as adjuncts rather than diagnoses, and reserve experimental geroprotectors for well-designed trials. The near-term opportunity is not radical life extension, but compression of morbidity through scalable, equitable, and evidence-based preservation of health span.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.7759/cureus.117984
- Canonical
- link ↗
- Fetched
- 2026-11-16 MST
Cite this
APA
VB, P., SB, T., J, C.A., HA, M., V, K., M, G.R., KT, S., AS, S., D, M.S., SVC, B., & R., C. (2026). Translating Geroscience Into Clinical Practice: Molecular Targets, Emerging Therapies, and Lifestyle Strategies for Healthy Longevity. <em>Cureus</em>. https://doi.org/10.7759/cureus.117984
Vancouver
VB P, SB T, J CA, HA M, V K, M GR, et al. Translating Geroscience Into Clinical Practice: Molecular Targets, Emerging Therapies, and Lifestyle Strategies for Healthy Longevity. Cureus. 2026. doi:10.7759/cureus.117984.
BibTeX
@article{pinnelli2026Transl,
title = {Translating Geroscience Into Clinical Practice: Molecular Targets, Emerging Therapies, and Lifestyle Strategies for Healthy Longevity.},
author = {Pinnelli VB and T SB and C A J and Mathew HA and Kandi V and G R M and Sam KT and Sucharitha AS and M S D and Batchu SVC and C R.},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.117984},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cureus 2026
Open access · CC-BY
Translating Geroscience Into Clinical Practice: Molecular Targets, Emerging Therapies, and Lifestyle Strategies for Healthy Longevity
The Journal of nutrition 2026
Citation only
Protein-Based Strategies and Mediterranean-Style Diets Show the Most Consistent Benefits for Sarcopenia in Older Adults.
Stresses 2025
Open access · CC-BY
Early Life Stress and Gut Microbiome Dysbiosis: A Narrative Review
Frontiers in Nutrition 2026
Open access · CC-BY
Potential impact of urolithin A on pathways relevant to sleep health: a mini review
Scientific reports 2026
Citation only
Systematic review and meta-analysis of the effects of exercise in older adults with sarcopenia.
SYNAPSES: Понимание различных дисциплин 2026
Open access · CC-BY